Preliminary US study findings support excellent results with CYPHER Sirolimus-eluting Stent
The CYPHER Sirolimus-eluting Stent demonstrated significant reductions in angiographic in-stent restenosis (94% less than control) and late lumen loss. The stent also showed excellent safety results, with a low event-free survival rate and no cases of acute or subacute thrombosis.